top of page
it's where dermatology lives
By John Evans, Associate Editor
Mar 17, 20172 min read
Anti-IL-31 drug shows promise in itch management for atopic dermatitis
A phase-II study of a new systemic therapy for atopic dermatitis has found that the therapy, the anti-interleukin (IL)31 antibody...
by Emily Innes-Leroux
Jun 4, 20161 min read
Skin Spectrum Summit: LSC most common chronic eczematous rash in patients with darker skin
Dr. Eileen Murray speaking at Skin Spectrum Summit, Vancouver, June 4, 2016/ Photo by Emily Innes-Leroux Chronic eczematous rashes are...
Featured Posts
bottom of page